Monday, February 03, 2020 1:51:03 PM
KN-Linkedin
This piece is a nice description of the BIEL portfolio. Its certainly going to be a great week, but more importantly a great couple of years. The head to head comparison with COX II and NSAIDS is a first in class win that presents a huge opportunity to make supported market claims. Combined with our 510k for all musculoskeletal pain it will give partners a huge product differentiator.
https://lnkd.in/eAeMDCe
What is going to make this week so great?
Could it be next week?
How many partners?
Another deal for Erin?
Who are all these partners?
Don't look at today's stock price but just keep an eye on the stock price late March early April.
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM
ECGI Holdings Accelerates Strategic Initiatives by Securing First of Two $125,000 Convertible Notes • ECGI • Jun 4, 2024 12:15 PM